WuXi AppTec to raise RMB5.7 billion on Shanghai Stock Exchange

The WuXi AppTec services and manufacturing unit of New WuXi Life Science Ltd. (Shanghai, China) received approval from the China Securities Regulatory Commission to list on the Shanghai Stock Exchange. According to a February prospectus, the company will raise RMB5.7 billion ($907.5 million) in net proceeds through the issuance of 104.2 million shares.

The company announced plans last March to list on a mainland China exchange (see BioCentury, March 30, 2017). ...